Picture

 

GeneFirst is  developing novel diagnostic methods and kits based on proprietary, robust,  sensitive DNA detection technology.
 
GeneFirst Ltd is a molecular diagnostics company working predominantly in the fields of infectious disease, cancer diagnostics and personalised medicine. GeneFirst offers robust easy-of-use, sensitive, and affordable molecular diagnostics technologies and products to researchers, clinicians and drug companies to enable accurate diagnosis and the delivery of safe and effective medicines. 

GeneFirst has a rich portfolio of patented technologies including MPA (multiplex Probe Amplification), MMD-PCR (Multiplex Mutation Detection PCR), and PCDR (Polymerase Chain Displacement Reaction).
       
Picture
    GeneFirst has won SEEDA Innovation Voucher award 

The South East England Development Agency (SEEDA) Innovation Voucher scheme has been set up to encourage and make it easier for more businesses in South East  England to buy support in the form of access to the facilities and expertise from the UK’s Universities and Public Research Establishments (PSREs) to support innovation and business improvement. GeneFirst has been awarded an Innovation Voucher 2011.
Picture

News

GeneFirst has won competitive funding through the Biomedical Catalyst of the Medical Research Council (MRC) and the Technology Strategy Board (TSB).
http://www.mrc.ac.uk/Newspublications/News/MRC008798

GeneFirst was selected for the Future Health Mission to Boston, presenting at AdvaMed 2012, the Medtech Conference.
http://futurehealthmission.com/mission-attendees/
http://www.londonlovesbusiness.com/business-news/uks-top-healthcare-startups-announced/3453.article